Miconazol Acis (Miconazole)

Miconazole, the active ingredient in Miconazol Acis, inhibits the fungal enzyme lanosterol 14α‑demethylase, which is essential for ergosterol synthesis. By blocking this step, the drug disrupts the formation of ergosterol, a critical component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death.

The dosage and frequency of Miconazol Acis are determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, and the area of skin involved. Patients should follow the prescriber’s instructions and the product label for proper application.

Safety data for Miconazol Acis during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this product.

To order Miconazol Acis, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the enquiry, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Miconazol Acis belongs to the azole class, similar to clotrimazole and ketoconazole. Compared with some alternatives, miconazole often provides a broader spectrum against dermatophytes and yeasts and may have a slightly faster symptom relief. Choice of agent depends on the specific pathogen, formulation preferences, and patient tolerance.

Miconazol Acis should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and extreme heat. Ensure the container is tightly closed when not in use to maintain product stability.

Miconazol Acis is applied topically to the affected skin area. Clean and dry the skin before use, then spread a thin layer of the cream or ointment over the lesion and surrounding margin, usually twice daily or as directed by a healthcare professional. Wash hands after application unless treating hand skin.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, extensive contact dermatitis, swelling of the face or lips, and systemic effects from significant absorption. Patients should discontinue use and seek immediate medical attention if they experience any signs of a severe reaction.

Individuals with a known hypersensitivity to miconazole, other azole antifungals, or any component of the formulation should avoid using Miconazol Acis. It should also be avoided on mucous membranes, the eyes, or on extensively broken skin unless specifically directed by a healthcare professional.